Hereditary Angioedema Market Size And Share

  • Report Code : TIPRE00005410
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Análisis de la cuota de mercado y oportunidades del angioedema hereditario (2025-2031)

Buy Now

Hereditary Angioedema Market Report Hereditary Angioedema Market Scope and Analysis Hereditary Angioedema Market Size and Share

Hereditary Angioedema Market Report Analysis

Hereditary Angioedema Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • BIOCRYST PHARMACEUTICALS, INC
  • CSL
  • Ionis Pharmaceuticals, Inc.
  • Merck Sharp & Dohme Corp
  • Pharming Group N. V.
  • Sanofi N. V.
  • Shire plc.
  • Teva Pharmaceutical Industries, Ltd.
  • Attune Pharmaceuticals

Regional Overview

  • América del Norte
  • Europa
  • Asia-Pacífico
  • América del Sur y Central
  • Medio Oriente y África

Market Segmentation

By Fármacos
  • inhibidor de la esterasa C1
  • inhibidor de calicreína
  • receptor de bradicinina
  • andrógenos atenuados
  • otros
By Vía de administración
  • subcutánea
  • intravenosa
  • oral
By Canal de Distribución
  • Farmacias Hospitalarias
  • Farmacias Minoristas
  • Comercio Electrónico
By Geografía
  • América del Norte
  • Europa
  • Asia-Pacífico
  • América del Sur y Central